Apimeds Pharmaceuticals US Inc (APUS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Apimeds Pharmaceuticals U...

    NYSE: APUS · Real-Time Price · USD
    1.86
    -0.03 (-1.59%)
    At close: Aug 28, 2025, 3:59 PM
    1.96
    5.39%
    After-hours: Aug 28, 2025, 07:56 PM EDT

    Apimeds Pharmaceuticals US Inc Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q4 2022
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Dec 31, 2022
    Cash & Equivalents
    		 8.74M 250.34K 3.46K 26.57K 63.33K 147.38K 410.48K 751.05K 6.17K
    Short-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Long-Term Assets
    		 184K n/a n/a n/a n/a n/a n/a n/a n/a
    Receivables
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Current Assets
    		 n/a n/a 9.6K 10.34K 10.34K 10.34K 11.6K n/a n/a
    Total Current Assets
    		 10.35M 259.9K 13.06K 36.91K 73.66K 157.72K 422.08K 922.73K 6.17K
    Property-Plant & Equipment
    		 13.14K n/a n/a n/a n/a n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Total Long-Term Assets
    		 197.13K n/a n/a n/a n/a n/a n/a n/a n/a
    Total Assets
    		 10.55M 259.9K 13.06K 36.91K 73.66K 157.72K 422.08K 922.73K 6.17K
    Account Payables
    		 n/a n/a n/a n/a n/a n/a n/a 62.07K 36.88K
    Deferred Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Short-Term Debt
    		 500K 623.62K 250K 250K 100K n/a n/a 260K 260K
    Other Current Liabilities
    		 182.66K 287.05K 180.55K 77K 26K n/a n/a n/a n/a
    Total Current Liabilities
    		 809K 1.77M 1.02M 761.4K 488.17K 136.48K 123.31K 377.07K 319.78K
    Long-Term Debt
    		 n/a 250K 346.84K 321.99K 299.46K 285.84K 266.89K 400K 400K
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 n/a 250K 346.84K 321.99K 299.46K 285.84K 266.89K 400K 400K
    Total Liabilities
    		 809K 2.02M 1.37M 1.08M 787.63K 422.32K 390.2K 777.07K 719.78K
    Total Debt
    		 500K 873.62K 596.84K 571.99K 399.46K 285.84K 266.89K 660K 660K
    Common Stock
    		 125.76K 79.04K 79.04K 205.5K 205.5K 205.5K 205.5K 150K 100K
    Retained Earnings
    		 -7.46M -4.79M -4.39M -4.08M -3.75M -3.3M -3M -2.43M -2.22M
    Comprehensive Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Shareholders Equity
    		 9.74M -1.76M -1.36M -1.05M -713.97K -264.6K 31.87K 145.66K -713.61K
    Total Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist